Literature DB >> 9497357

Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha.

S W Kang1, H Z Chae, M S Seo, K Kim, I C Baines, S G Rhee.   

Abstract

Mammalian tissues express three immunologically distinct peroxiredoxin (Prx) proteins (Prx I, II, and III), which are the products of distinct genes. With the use of recombinant proteins Prx I, II, and III, all have now been shown to possess peroxidase activity and to rely on Trx as a source of reducing equivalents for the reduction of H2O2. Prx I and II are cytosolic proteins, whereas Prx III is localized in mitochondria. Transient overexpression of Prx I or II in cultured cells showed that they were able to eliminate the intracellular H2O2 generated in response to growth factors. Moreover, the activation of nuclear factor kappaB (NFkappaB) induced by extracellularly added H2O2 or tumor necrosis factor-alpha was blocked by overproduction of Prx II. These results suggest that, together with glutathione peroxidase and catalase, Prx enzymes likely play an important role in eliminating peroxides generated during metabolism. In addition, Prx I and II might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentration of H2O2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497357     DOI: 10.1074/jbc.273.11.6297

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  148 in total

1.  Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization.

Authors:  L M Baker; A Raudonikiene; P S Hoffman; L B Poole
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

2.  A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells.

Authors:  Igor Paron; Angela D'Elia; Chiara D'Ambrosio; Andrea Scaloni; Federica D'Aurizio; Alan Prescott; Giuseppe Damante; Gianluca Tell
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

3.  Redox systems of the cell: possible links and implications.

Authors:  Kumuda C Das; Carl W White
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

4.  Molecular cloning and characterization of peroxiredoxin from Toxoplasma gondii.

Authors:  E S Son; K J Song; J C Shin; H W Nam
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

5.  Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Jenn-Han Chen; Yu-Wang Chang; Chen-Wen Yao; Tzong-Shi Chiueh; Su-Chin Huang; Ko-Yi Chien; An Chen; Feng-Yee Chang; Chi-Huey Wong; Yu-Ju Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

6.  The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein.

Authors:  Sonali Jalan Rawat; Caretha L Creasy; Jeffrey R Peterson; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

7.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

8.  Evidence that peroxiredoxins are novel members of the thioredoxin fold superfamily.

Authors:  E Schröder; C P Ponting
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

9.  Regulation of thioredoxin by ceramide in retinal pigment epithelial cells.

Authors:  Parameswaran G Sreekumar; Yi Ding; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

10.  Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespan.

Authors:  Mi-Jung Kim; Chul Han; Karessa White; Hyo-Jin Park; Dalian Ding; Kevin Boyd; Christina Rothenberger; Upal Bose; Peter Carmichael; Paul J Linser; Masaru Tanokura; Richard Salvi; Shinichi Someya
Journal:  Exp Gerontol       Date:  2020-08-28       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.